Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Target discovered that halts osteoarthritis-type knee cartilage degeneration

In a mouse study, researchers used nanotechnology and previous knowledge of a protein pathway to significantly reduce knee […]

January 15, 2021 Uncategorized

New delivery method promises relief from antipsychotic medication’s adverse side effects

A team of neuroscientists and engineers has created a nasal spray to deliver antipsychotic medication directly to the […]

January 15, 2021 Uncategorized

Detecting COVID-19 antibodies in 10-12 seconds

Researchers at Carnegie Mellon University report findings on an advanced nanomaterial-based biosensing platform that detects, within seconds, antibodies […]

January 15, 2021 Uncategorized

Imaging: scientists paint multicolor atlas of the brain

A novel technique developed by Columbia researchers known as NeuroPAL helps tease out the dynamics of neural networks […]

January 15, 2021 Uncategorized

Trust is ordered to pay {pound}7500 to man who was not “best fit” for role with young women

An employment tribunal has ordered an NHS trust to pay £7580 (€8524; $10 348) for sex and age […]

January 15, 2021 Uncategorized

Acute coronary syndromes: summary of updated NICE guidance

What you need to knowPrasugrel is recommended as dual anti-platelet therapy in combination with aspirin for people with […]

January 15, 2021 Guideline summaries

Fixing America’s covid response in the Biden era

Celine Gounder is an infectious diseases expert and epidemiologist who has worked on Ebola, tuberculosis (TB), and HIV […]

January 15, 2021 COVID-19

Boehringer Ingelheim and Enara Bio join forces to discover cancer immunotherapies

Agreement will leverage Enara’s novel Dark Antigen discovery platform

January 15, 2021 Uncategorized

Verona completes enrolment in pilot study of potential COVID-19 inhaler

Ensinfentrine is a first-in-class inhaled inhibitor of the enzymes phosphodiesterase 3 and 4

January 15, 2021 Uncategorized

US breakthrough designation for ligelizumab in chronic spontaneous urticaria

In a Phase IIb trial, more patients experienced complete resolution of hives with ligelizumab compared to Xolair

January 15, 2021 Uncategorized

Posts navigation

Posts pagination

« Previous 1 … 1,587 1,588 1,589 … 2,021 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy